4 Healthcare Stock Stories To Heal the Fitful Trading Day

Johnson & Johnson (NYSE:JNJ): Closing price $84.61

The Johnson & Johnson subsidiary Cordis Corporation has announced the European CE marking and FDA approval of additional sizes of its SLEEK OTW platform, which is a 0.014-inch ultra-low profile percutaneous transluminal angioplasty dilatation catheter. This catheter is a highly deliverable balloon catheter, created to treat patients undergoing peripheral angioplasty procedures below the knee. The device was first introduced on a global basis in 2011, and Cordis will begin commercializing these new sizes immediately in several countries worldwide.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

JNJ